Minerva Neurosciences, Inc.
NERV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001598646
No open-market purchases or sales by Minerva Neurosciences, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $234.8M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Minerva Neurosciences, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 22 | 21 | −1 |
| Shares | 1.95M | 1.94M | −7.45K (−0.4%) |
| Value | $3.31M | $3.34M | +$31.8K (+1.0%) |
New holders (3)
Institutions that held Minerva Neurosciences, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ADAR1 Capital Management, LLC | 12,406 | $21.3K | 0.00% |
| Jones Financial Companies LLLP | 57 | $101 | 0.00% |
| Raymond James Financial Inc | 25 | $43 | 0.00% |
Sold out (4)
Institutions that held Minerva Neurosciences, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Citadel Advisors LLC | 12,915 | $22.0K |
| Wells Fargo & Company | 1,938 | $3.29K |
| FMR LLC | 25 | $43 |
| JPMorgan Chase & Co | 17 | $29 |